Joana P. Bernardes

1. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease
   2021/03/02 by Stefan Schreiber, Konrad Aden, Joana P. Bernardes +24 · 27 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · Immunology and Microbiology · #Inflammatory Bowel Disease #Cytokine Signaling Pathways and Interactions #Psoriasis: Treatment and Pathogenesis